Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases.
about
Biochemical markers of ongoing joint damage in rheumatoid arthritis--current and future applications, limitations and opportunities.The calcitonin and glucocorticoids combination: mechanistic insights into their class-effect synergy in experimental arthritisDissociation of bone resorption and bone formation in adult mice with a non-functional V-ATPase in osteoclasts leads to increased bone strengthInvestigation of the diurnal variation in bone resorption for optimal drug delivery and efficacy in osteoporosis with oral calcitoninAlterations in osteoclast function and phenotype induced by different inhibitors of bone resorption--implications for osteoclast qualityThe assessment of fracture risk.Antioxidant Effect of Fructus Ligustri Lucidi Aqueous Extract in Ovariectomized Rats Is Mediated through Nox4-ROS-NF-κB PathwayEstrogen action on bone marrow osteoclast lineage cells of postmenopausal women in vivo.Computer-Automated Static, Dynamic and Cellular Bone HistomorphometryRole of calcitonin gene-related peptide in bone repair after cyclic fatigue loading.Myeloid DAP12-associating lectin (MDL)-1 regulates synovial inflammation and bone erosion associated with autoimmune arthritisOsteoclasts and odontoclasts: signaling pathways to development and disease.Cathepsin K in treatment monitoring following intravenous zoledronic acidChanges in the vitamin D endocrine system and bone turnover after oral vitamin D3 supplementation in healthy adults: results of a randomised trial.Alterations in bone and erythropoiesis in hemolytic anemia: comparative study in bled, phenylhydrazine-treated and Plasmodium-infected mice.Dimethyloxalylglycine prevents bone loss in ovariectomized C57BL/6J mice through enhanced angiogenesis and osteogenesis.Biochemical markers for assessment of calcium economy and bone metabolism: application in clinical trials from pharmaceutical agents to nutritional products.Effects of HIV infection and antiretroviral therapy with ritonavir on induction of osteoclast-like cells in postmenopausal womenSystemic effects of ulna loading in male rats during functional adaptationPremenopausal women with idiopathic low-trauma fractures and/or low bone mineral density.Sustained release of adiponectin improves osteogenesis around hydroxyapatite implants by suppressing osteoclast activity in ovariectomized rabbitsEwing's sarcoma of bone tumor cells produces MCSF that stimulates monocyte proliferation in a novel mouse model of Ewing's sarcoma of bone.Effectiveness of resistance training or jumping-exercise to increase bone mineral density in men with low bone mass: A 12-month randomized, clinical trialSuppressed bone remodeling in black bears conserves energy and bone mass during hibernation.Will posttranslational modifications of brain proteins provide novel serological markers for dementias?Effect of fangchinoline on root resorption during rat orthodontic tooth movementSafety and effectiveness of daily teriparatide in a prospective observational study in patients with osteoporosis at high risk of fracture in Japan: final report.Regulation of bone turnover by sex steroids in menSerum N-Terminal Propeptide of Collagen Type I is Associated with the Number of Bone Metastases in Breast and Prostate Cancer and Correlates to Other Bone Related Markers.Alendronate treatment results in similar levels of trabecular bone remodeling in the femoral neck and vertebra.Biochemical markers and the FDA Critical Path: how biomarkers may contribute to the understanding of pathophysiology and provide unique and necessary tools for drug development.Oral salmon calcitonin--pharmacology in osteoporosis.Hypercalcemia and altered biochemical bone markers in post-bone marrow transplantation osteopetrosis: a case report and literature review.Use of bone turnover markers in clinical osteoporosis assessment in women: current issues and future options.Biomarkers of cartilage and surrounding joint tissue.Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.Ferric ion could facilitate osteoclast differentiation and bone resorption through the production of reactive oxygen species.Dosing time-dependent effect of raloxifene on plasma plasminogen activator inhibitor-1 concentrations in post-menopausal women with osteoporosis.Inhibition of markers of bone resorption by consumption of vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women.Effects of morning vs. evening teriparatide injection on bone mineral density and bone turnover markers in postmenopausal osteoporosis.
P2860
Q27687777-9F777B34-3E65-4153-B0D9-D26981EEC201Q28485981-64DDBA42-EB76-4564-AFC3-53823BB6C675Q28743063-6097A4EF-2B70-48A0-855D-5CA6D18AF02BQ33389566-F6E02EC4-D45B-4AE9-ADE8-0E3B3DD5D886Q33591699-B190EA41-5595-44FD-BE3D-A2217D7EE10CQ33685092-BE266329-6D6D-48B0-B3C5-3D951A7746BDQ33710878-1433E46E-BB41-48C2-B759-67C0ADFAB43EQ33742652-B3A4E0F3-E8D9-45FB-AAE4-AB7034E05752Q33878094-B5B5DAF0-D28F-4639-838E-3146F4FE4707Q33939086-A4F9B8D1-4D81-4085-8F34-50F167C56C0EQ34102750-CB6F195F-A657-4AEC-9C72-4255897B15A9Q34127948-D36A6624-F175-412F-8CE3-EFEF9DEA5E09Q34265281-250F8CF0-7EA0-4964-AE3E-B48F69992265Q34303149-C9B00261-BE03-4E93-8031-89C722AC921BQ34430802-5F5EE8D6-A09E-4D30-8769-945DB569B02CQ34506361-7DA56671-FA4A-433C-AD29-7C0A889BA501Q35017714-5F483233-DAE5-42CB-A8C5-58C34930F2C0Q35055196-79EC57E1-3803-4885-AF32-19A424507E75Q35156326-C2A05EFB-3731-4BF0-89E9-E766D3FCBDCCQ35501419-F67FB5DD-8ED9-4937-8A5C-083D3B5655DBQ35688801-72582634-475E-476F-B734-1D630ED3753FQ35850371-BE256B30-D853-47E5-B467-893616F66B26Q35854611-72E6DD6F-1973-4B22-BBAD-78E8227A174BQ35878081-E14B7845-FA13-4807-9592-E35C2E95751CQ36072517-0958C9B1-0BA5-4031-AFF4-57BD20B9EE1FQ36349832-37272B88-FA83-40A6-B1E5-A7B1EF74DC09Q37082771-5D942B87-B072-401B-A482-4BB0F5AC5D3EQ37172776-22DF9025-A1B2-469C-A9A3-89ADB18CC27EQ37218904-EB4A7A55-4CE1-4BE3-877E-23AD9D403BE6Q37233308-74055270-4320-49E3-8F53-0774308E88FEQ37462448-4C1E618C-7014-4DAD-B079-F52D7F47F8F4Q37798836-F6837138-C477-42FF-9D6F-87C0A2EEF47EQ37842728-378A5932-53C1-4AF6-BB8A-40CAECEFCDBFQ37951107-4370F82C-D68A-4BF7-9659-83491E6D0004Q38239828-F94EE18F-7A94-4815-8642-0DDCCBE07537Q39034377-DC488BBD-A928-4A1A-A0B9-06EEB8A3279AQ39351721-80C56EE0-472A-4B78-AF62-80FA0FFE516CQ45278377-19755E73-BD89-4CCB-865C-1A26CA8ACD8EQ45972735-7A6F08C8-9BBB-46D9-8AE3-166530404DF8Q46583319-C73FD8EC-5186-4026-AF28-B31B8911170E
P2860
Assessment of osteoclast number and function: application in the development of new and improved treatment modalities for bone diseases.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Assessment of osteoclast numbe ...... modalities for bone diseases.
@ast
Assessment of osteoclast numbe ...... modalities for bone diseases.
@en
type
label
Assessment of osteoclast numbe ...... modalities for bone diseases.
@ast
Assessment of osteoclast numbe ...... modalities for bone diseases.
@en
prefLabel
Assessment of osteoclast numbe ...... modalities for bone diseases.
@ast
Assessment of osteoclast numbe ...... modalities for bone diseases.
@en
P2093
P1476
Assessment of osteoclast numbe ...... modalities for bone diseases.
@en
P2093
C Christiansen
K Henriksen
M A Karsdal
P D Delmas
P2888
P304
P356
10.1007/S00198-006-0286-8
P407
P577
2006-11-24T00:00:00Z